Scholarly Index

Ian Chi Kei Wong

University of Hong Kong; 30,770 total citations; 989 total publications; best world rank #16

University of Hong Kong

30,770Total citations
989Total publications
86H-index

Published ranking records

FieldWindowWorld rankNational rankImpact score
Medical and Health Sciences2021-2025246CN 2699.95
Pediatrics, Perinatology and Child HealthLifetime155CN 399.54
Psychiatry and Mental healthLifetime491CN 398.33
Geriatrics and GerontologyLifetime116CN 397.17
Emergency Medical ServicesLifetime511CN 795.19
ToxicologyLifetime251CN 286.84
OphthalmologyLifetime864CN 2669.55
Infectious Diseases2021-202592CN 1698.52
Cardiology and Cardiovascular Medicine2021-2025291CN 697.44
Psychiatry and Mental health2021-2025176CN 696.53
Endocrinology, Diabetes and Metabolism2021-2025220CN 496.04
Epidemiology2021-2025533CN 5995.15
Surgery2021-2025571CN 5295.22
Pediatrics, Perinatology and Child Health2021-2025379CN 1691.47
Clinical Neurology2021-2025277CN 1291.64
Clinical Psychology2021-2025725CN 2592.39
Public, Environmental and Occupational Health2021-2025949CN 5390.23
Oncology2021-2025958CN 12282.67
Pharmaceutical studies and practicesLifetime16CN 199.63
Pharmaceutical Practices and Patient OutcomesLifetime27CN 199.38
Child and Adolescent HealthLifetime52CN 199.12
Pharmacovigilance and Adverse Drug ReactionsLifetime18CN 198.69
COVID-19 Clinical Research StudiesLifetime361CN 5498.47
Long-Term Effects of COVID-19Lifetime283CN 1997.60
Pharmacological Effects and Toxicity StudiesLifetime254CN 398.55
Attention Deficit Hyperactivity DisorderLifetime189CN 198.47
SARS-CoV-2 and COVID-19 ResearchLifetime595CN 9098.08
COVID-19 and healthcare impactsLifetime304CN 1095.97
Patient Safety and Medication ErrorsLifetime116CN 198.14
Epilepsy research and treatmentLifetime560CN 397.65
Pediatric Pain Management TechniquesLifetime553CN 1094.55
Pharmaceutical Economics and PolicyLifetime785CN 1092.34
Safe Handling of Antineoplastic DrugsLifetime491CN 570.78
COVID-19 Clinical Research Studies2021-2025134CN 1799.24
SARS-CoV-2 and COVID-19 Research2021-2025198CN 3199.09
COVID-19 and healthcare impacts2021-202596CN 297.62
Long-Term Effects of COVID-192021-2025157CN 698.10
Blood Pressure and Hypertension Studies2021-2025222CN 1396.16
COVID-19 and Mental Health2021-2025554CN 6295.42
Viral Infections and Immunology Research2021-2025217CN 4992.22
Attention Deficit Hyperactivity Disorder2021-2025162CN 993.80
Chronic Disease Management Strategies2021-2025276CN 2292.61
Heparin-Induced Thrombocytopenia and Thrombosis2021-202557CN 592.80
Vaccine Coverage and Hesitancy2021-2025664CN 5692.48
Pharmaceutical studies and practices2021-2025239CN 588.49
Lipoproteins and Cardiovascular Health2021-2025624CN 4489.56
Pharmaceutical Practices and Patient Outcomes2021-2025587CN 1188.12
Bone health and osteoporosis research2021-2025473CN 4886.47
Bipolar Disorder and Treatment2021-2025547CN 3786.54
Hip and Femur Fractures2021-2025798CN 9586.13
Pharmacovigilance and Adverse Drug Reactions2021-2025145CN 2383.63
Diabetes, Cardiovascular Risks, and Lipoproteins2021-2025906CN 20384.46
Antiplatelet Therapy and Cardiovascular Diseases2021-2025900CN 8183.35
Pharmaceutical Economics and Policy2021-2025425CN 1782.56
Diabetes Management and Education2021-2025933CN 4473.28
Biosimilars and Bioanalytical Methods2021-2025995CN 5971.65
Potassium and Related Disorders2021-2025546CN 1765.96